SHMT2 and colorectal cancer: Moreover, our clinical analysis showed that high expression levels of SIRT3 in colorectal cancer patients were correlated with a shorter survival time, which is partially due to deacetylated SHMT2 and activated serine consumption in colorectal cancer cells.